 |
50 Diseases |  |
20 Trials |
|
20 Trials |  |
1121 News |  |
| «12...3456789101112131415» |
- | pitavastatin / Generic mfg.
Phase classification: REPRIEVE: Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults (clinicaltrials.gov) - Jun 16, 2017
P4, N=6500, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Phase classification: P3 --> P4
- | pitavastatin / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention (clinicaltrials.gov) - May 9, 2017
P=N/A, N=266, Completed, Sponsor: Milton S. Hershey Medical Center
Phase classification: P3 --> P4 Active, not recruiting --> Completed | N=372 --> 266 | Trial primary completion date: Oct 2013 --> Apr 2015
- || pitavastatin / Generic mfg.
Trial primary completion date: SIPHON: to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia (clinicaltrials.gov) - Mar 10, 2017
P4, N=313, Active, not recruiting, Sponsor: JW Pharmaceutical
Active, not recruiting --> Completed | N=372 --> 266 | Trial primary completion date: Oct 2013 --> Apr 2015 Trial primary completion date: Aug 2015 --> May 2016
- | pitavastatin / Generic mfg.
New trial: PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332) (clinicaltrials.gov) - Mar 3, 2017
P=N/A, N=600, Recruiting, Sponsor: AIDS Clinical Trials Group
- |||| pitavastatin / Generic mfg.
Enrollment open, Trial primary completion date: Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome (clinicaltrials.gov) - Feb 9, 2017
P4, N=500, Recruiting, Sponsor: Seoul National University Hospital
Trial primary completion date: Aug 2015 --> May 2016 Not yet recruiting --> Recruiting | Trial primary completion date: May 2019 --> Nov 2019
- pitavastatin / Generic mfg.
Enrollment closed: ELEVATE: Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis (clinicaltrials.gov) - Dec 27, 2016
P4, N=1000, Active, not recruiting, Sponsor: Korea University Anam Hospital
Not yet recruiting --> Recruiting | Trial primary completion date: May 2019 --> Nov 2019 Recruiting --> Active, not recruiting
- || pitavastatin / Generic mfg.
Phase classification: REPRIEVE: Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults (clinicaltrials.gov) - Dec 23, 2016
P3, N=6500, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Active, not recruiting Phase classification: P4 --> P3
- Januvia (sitagliptin) / Merck (MSD), pitavastatin / Generic mfg.
Enrollment closed, Trial primary completion date: Drug Transporter Interaction Study PHENTRA_2015_KPUK (clinicaltrials.gov) - Nov 15, 2016
P4, N=24, Active, not recruiting, Sponsor: University of Cologne
Phase classification: P4 --> P3 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Dec 2017
- | pitavastatin / Generic mfg.
New P4 trial: DO-IT: Dyslipidemia of Obesity Intervention in Teens (clinicaltrials.gov) - Nov 7, 2016
P4, N=354, Not yet recruiting, Sponsor: New England Research Institutes
- ||||| pitavastatin / Generic mfg.
New P4 trial: Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome (clinicaltrials.gov) - Oct 19, 2016
P4, N=500, Not yet recruiting, Sponsor: Seoul National University Hospital
- |||| pitavastatin / Generic mfg.
Trial completion, Trial primary completion date: EPOCH: Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients (clinicaltrials.gov) - Oct 14, 2016
P4, N=85, Completed, Sponsor: Asan Medical Center
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Dec 2017 Active, not recruiting --> Completed | Trial primary completion date: May 2017 --> Oct 2016
- | pimodivir (JNJ-3872) / J&J
New P1 trial: A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872 (clinicaltrials.gov) - Sep 6, 2016
P1, N=48, Active, not recruiting, Sponsor: Alios Biopharma Inc.
- | pitavastatin / Generic mfg.
New P4 trial: Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease (clinicaltrials.gov) - Aug 11, 2016
P4, N=72, Active, not recruiting, Sponsor: Dong-A University
- pitavastatin / Generic mfg.
Trial completion, Trial primary completion date: Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents (clinicaltrials.gov) - Jul 28, 2016
P4, N=120, Completed, Sponsor: Yonsei University
Active, not recruiting --> Completed | Trial primary completion date: May 2017 --> Oct 2016 Recruiting --> Completed | Trial primary completion date: Jul 2012 --> May 2015
- pitavastatin / Generic mfg.
New P3 trial: Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo (clinicaltrials.gov) - Jun 16, 2016
P3, N=2, Terminated, Sponsor: Kowa Research Institute, Inc.
- | pitavastatin / Generic mfg.
Enrollment change, Trial termination: Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia (clinicaltrials.gov) - Jun 9, 2016
P3, N=216, Terminated, Sponsor: Kowa Research Institute, Inc.
Recruiting --> Completed | Trial primary completion date: Jul 2012 --> May 2015 N=300 --> 216 | Recruiting --> Terminated
- Januvia (sitagliptin) / Merck (MSD), pitavastatin / Generic mfg.
New P4 trial: Drug Transporter Interaction Study PHENTRA_2015_KPUK (clinicaltrials.gov) - Apr 19, 2016
P4, N=24, Recruiting, Sponsor: University of Cologne
- |||||||||| pitavastatin / Generic mfg.
New P3 trial: Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia (clinicaltrials.gov) - Feb 1, 2016
P3, N=300, Recruiting, Sponsor: Kowa Research Institute, Inc.
- | pimodivir (JNJ-3872) / J&J
Trial completion: A Study to Investigate the Effect of JNJ-63623872 on Pitavastatin in Healthy Participants (clinicaltrials.gov) - Jan 27, 2016
P1, N=14, Completed, Sponsor: Janssen Research & Development, LLC
N=300 --> 216 | Recruiting --> Terminated Recruiting --> Completed
- | pitavastatin / Generic mfg.
Trial completion: A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers (clinicaltrials.gov) - Jan 15, 2016
P1, N=18, Completed, Sponsor: Kowa Research Institute, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- | pitavastatin / Generic mfg.
New P1 trial: A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers (clinicaltrials.gov) - Dec 17, 2015
P1, N=18, Active, not recruiting, Sponsor: Kowa Research Institute, Inc.
- pimodivir (JNJ-3872) / J&J
Enrollment open: A Study to Investigate the Effect of JNJ-63623872 on Pitavastatin in Healthy Participants (clinicaltrials.gov) - Dec 2, 2015
P1, N=14, Recruiting, Sponsor: Janssen Research & Development, LLC
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | pimodivir (JNJ-3872) / J&J
New P1 trial: A Study to Investigate the Effect of JNJ-63623872 on Pitavastatin in Healthy Participants (clinicaltrials.gov) - Nov 3, 2015
P1, N=14, Not yet recruiting, Sponsor: Janssen Research & Development, LLC
- | pitavastatin / Generic mfg.
New P4 trial: ELEVATE: Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis (clinicaltrials.gov) - Sep 9, 2015
P4, N=1000, Recruiting, Sponsor: Korea University Anam Hospital
- ||| pitavastatin / Generic mfg.
Enrollment closed: EPOCH: Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients (clinicaltrials.gov) - Jun 24, 2015
P4, N=82, Active, not recruiting, Sponsor: Asan Medical Center
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- pitavastatin / Generic mfg.
New P4 trial: Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir (clinicaltrials.gov) - May 15, 2015
P4, N=24, Completed, Sponsor: Ramathibodi Hospital
- pitavastatin / Generic mfg.
Enrollment open: REPRIEVE: Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults (clinicaltrials.gov) - Mar 24, 2015
P4, N=6500, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- pitavastatin / Generic mfg.
Enrollment open, Trial primary completion date: Effects of Pitavastatin on Insulin Sensitivity and Liver Fat (clinicaltrials.gov) - Feb 20, 2015
P=N/A, N=50, Recruiting, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2017 --> Mar 2018
- | pitavastatin / Generic mfg.
New P4 trial: REPRIEVE: Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults (clinicaltrials.gov) - Jan 22, 2015
P4, N=6500, Not yet recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- ||| pitavastatin / Generic mfg.
Trial completion, Trial primary completion date: Livalo Acute Myocardial Infarction Study (LAMIS) (clinicaltrials.gov) - Dec 17, 2014
P=N/A, N=1000, Completed, Sponsor: JW Pharmaceutical
Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2017 --> Mar 2018 Recruiting --> Completed | Trial primary completion date: Aug 2014 --> May 2014
- |||| pitavastatin / Generic mfg.
Enrollment open: EPOCH: Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients (clinicaltrials.gov) - Dec 6, 2014
P4, N=82, Recruiting, Sponsor: Asan Medical Center
Recruiting --> Completed | Trial primary completion date: Aug 2014 --> May 2014 Not yet recruiting --> Recruiting
- pitavastatin / Generic mfg.
Enrollment closed, Trial primary completion date: Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS) (clinicaltrials.gov) - Sep 28, 2014
P=N/A, N=1550, Active, not recruiting, Sponsor: Chieko Hamada
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2014 --> Jul 2014
- |||| frovocimab (LY3015014) / Eli Lilly
Trial completion: A Study of LY3015014 in Participants With High Cholesterol (clinicaltrials.gov) - Jul 1, 2014
P2, N=528, Completed, Sponsor: Eli Lilly and Company
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2014 --> Jul 2014 Active, not recruiting --> Completed
- ||||| pitavastatin / Generic mfg.
New P4 trial: EPOCH: Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients (clinicaltrials.gov) - May 19, 2014
P4, N=82, Not yet recruiting, Sponsor: Asan Medical Center
- || pitavastatin / Generic mfg.
Trial primary completion date: Livalo Acute Myocardial Infarction Study (LAMIS) (clinicaltrials.gov) - May 11, 2014
P=N/A, N=1000, Recruiting, Sponsor: JW Pharmaceutical
Active, not recruiting --> Completed Trial primary completion date: Dec 2013 --> Aug 2014
- || pitavastatin / Generic mfg.
Trial primary completion date: SAPHIRE: South Korean Pitavastatin Heart Failure Study (clinicaltrials.gov) - May 11, 2014
P4, N=70, Completed, Sponsor: JW Pharmaceutical
Trial primary completion date: Dec 2013 --> Aug 2014 Trial primary completion date: Jan 2013 --> May 2013
- | pitavastatin / Generic mfg.
Trial completion date: Livalo Acute Myocardial Infarction Study (LAMIS) (clinicaltrials.gov) - May 11, 2014
P=N/A, N=1000, Recruiting, Sponsor: JW Pharmaceutical
Trial primary completion date: Jan 2013 --> May 2013 Trial completion date: Dec 2013 --> Dec 2014
- || pitavastatin / Generic mfg.
Trial completion date: SAPHIRE: South Korean Pitavastatin Heart Failure Study (clinicaltrials.gov) - May 11, 2014
P4, N=70, Completed, Sponsor: JW Pharmaceutical
Trial completion date: Dec 2013 --> Dec 2014 Trial completion date: Jan 2013 --> May 2014
- |||| pitavastatin / Generic mfg.
Trial completion: SAPHIRE: South Korean Pitavastatin Heart Failure Study (clinicaltrials.gov) - May 11, 2014
P4, N=70, Completed, Sponsor: JW Pharmaceutical
Trial completion date: Jan 2013 --> May 2014 Active, not recruiting --> Completed
- ||||| pitavastatin / Generic mfg.
New P4 trial: SIPHON: to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia (clinicaltrials.gov) - Feb 4, 2014
P4, N=318, Recruiting, Sponsor: JW Pharmaceutical
- ||| frovocimab (LY3015014) / Eli Lilly
Enrollment closed: A Study of LY3015014 in Participants With High Cholesterol (clinicaltrials.gov) - Feb 4, 2014
P2, N=528, Active, not recruiting, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- pitavastatin / Generic mfg.
Trial completion: SPARQ: A Study Comparing CoQ10 Levels While Taking 3 Different Statins (clinicaltrials.gov) - Feb 2, 2014
P4, N=135, Completed, Sponsor: University of Kansas
Recruiting --> Active, not recruiting Recruiting --> Completed
- pitavastatin / Generic mfg.
Enrollment change: COMPACT-CAD: Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD) (clinicaltrials.gov) - Oct 10, 2013
P4, N=129, Completed, Sponsor: Kumamoto University
Recruiting --> Completed N=200 --> 129
- pitavastatin / Generic mfg.
Trial completion: COMPACT-CAD: Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD) (clinicaltrials.gov) - Oct 10, 2013
P4, N=129, Completed, Sponsor: Kumamoto University
N=200 --> 129 Recruiting --> Completed
- pitavastatin / Generic mfg.
Trial completion: Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) (clinicaltrials.gov) - Sep 4, 2013
P4, N=1240, Completed, Sponsor: Tokyo University
Recruiting --> Completed Recruiting --> Completed
- pitavastatin / Generic mfg.
Enrollment change: CAPITAIN: Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome (clinicaltrials.gov) - Jul 18, 2013
P1, N=14, Completed, Sponsor: Kowa Research Europe
Recruiting --> Completed N=20 --> 14
- | pitavastatin / Generic mfg.
Trial completion: CAPITAIN: Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome (clinicaltrials.gov) - Jul 18, 2013
P1, N=14, Completed, Sponsor: Kowa Research Europe
N=20 --> 14 Recruiting --> Completed
- ||||| frovocimab (LY3015014) / Eli Lilly
New P2 trial: A Study of LY3015014 in Participants With High Cholesterol (clinicaltrials.gov) - Jun 30, 2013
P2, N=528, Active, not recruiting, Sponsor: Eli Lilly and Company
- ||||||| pitavastatin / Generic mfg.
Trial completion: Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia (clinicaltrials.gov) - Jun 13, 2013
P3, N=202, Completed, Sponsor: Orient Pharma Co., Ltd.
Recruiting --> Completed Active, not recruiting --> Completed
- | pitavastatin / Generic mfg.
New P4 trial: Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction (clinicaltrials.gov) - Jun 5, 2013
P4, N=404, Not yet recruiting, Sponsor: Gachon University Gil Medical Center